SILK | Silk Road Medical, Inc Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	27.49 - 27.50
52 Week Range	6.08 - 27.51
Beta	1.53
Implied Volatility	68.91%
IV Rank	N/A
Day's Volume	2,308,974
Average Volume	2,061,398
Shares Outstanding	40,632,100
Market Cap	1,116,976,429
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2019-04-04

Valuation
Profitability
Growth
Health
P/E Ratio	-18.96
Forward P/E Ratio	N/A
EPS	-1.45
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	474
Country	USA
Website	SILK

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

SILK's peers: TMDX

*Chart delayed

Analyzing fundamentals for SILK we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is passable. For more detailed analysis please see SILK Fundamentals page.

Watching at SILK technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on SILK Technicals page.